CA1334576C - Antiviral pharmaceutical compositions and process for preparing same - Google Patents

Antiviral pharmaceutical compositions and process for preparing same

Info

Publication number
CA1334576C
CA1334576C CA000593270A CA593270A CA1334576C CA 1334576 C CA1334576 C CA 1334576C CA 000593270 A CA000593270 A CA 000593270A CA 593270 A CA593270 A CA 593270A CA 1334576 C CA1334576 C CA 1334576C
Authority
CA
Canada
Prior art keywords
acid
fatty acid
amino acid
omega
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000593270A
Other languages
English (en)
French (fr)
Inventor
Istvan Racz
Gyongyver Soos
Miklos Koller
Peter Literati Nagy
Maria Boros
Jeno Szilbereky
Gabor Nemeth
Alan Pinter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOREX KFT
Original Assignee
BIOREX KFT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOREX KFT filed Critical BIOREX KFT
Application granted granted Critical
Publication of CA1334576C publication Critical patent/CA1334576C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000593270A 1988-03-09 1989-03-09 Antiviral pharmaceutical compositions and process for preparing same Expired - Fee Related CA1334576C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU881132A HU209973B (en) 1988-03-09 1988-03-09 Process for production of antiviral and immunstimular pharmaceutical composition
HU1132/88 1988-03-09

Publications (1)

Publication Number Publication Date
CA1334576C true CA1334576C (en) 1995-02-28

Family

ID=10952974

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000593270A Expired - Fee Related CA1334576C (en) 1988-03-09 1989-03-09 Antiviral pharmaceutical compositions and process for preparing same

Country Status (14)

Country Link
JP (1) JPH01316316A (ja)
KR (1) KR890014103A (ja)
BE (1) BE1002890A3 (ja)
CA (1) CA1334576C (ja)
CH (1) CH678918A5 (ja)
DE (1) DE3907649C2 (ja)
FI (1) FI94591C (ja)
FR (1) FR2628324B1 (ja)
GB (1) GB2216418B (ja)
HU (1) HU209973B (ja)
IT (1) IT1229562B (ja)
LU (1) LU87471A1 (ja)
NL (1) NL8900574A (ja)
SE (1) SE8900828L (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
JPH04279523A (ja) * 1991-01-11 1992-10-05 Nisshin Flour Milling Co Ltd 免疫賦活油脂加工品
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
CA2159116A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5767156A (en) * 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
WO1996030381A1 (en) * 1995-03-28 1996-10-03 Novo Nordisk A/S Immunosuppressive agents
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
BRPI0820802A2 (pt) * 2007-12-17 2015-06-16 Univ Florida Materiais e métodos para tratamento de proliferação vascular ocular patológica
FR3031451B1 (fr) * 2015-01-13 2018-03-23 Greentech Sel d'un triglyceride, preparation et utilisations
EP3248467A1 (de) 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
EP3463310B1 (en) * 2016-05-25 2023-07-05 Evonik Operations GmbH Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
WO2019008101A1 (en) 2017-07-06 2019-01-10 Evonik Technochemie Gmbh ENTERICALLY COATED SOLID DOSAGE FORM COMPRISING AMINO ACIDS SALTS OF OMEGA-3 FATTY ACIDS
KR102628351B1 (ko) 2017-08-15 2024-01-25 에보니크 오퍼레이션즈 게엠베하 오메가-3 지방산 아미노산 염의 높은 활성 성분 함량을 갖는 정제
MX2022001570A (es) 2019-08-08 2022-03-02 Evonik Operations Gmbh Proceso de flujo descendente para la produccion de sales de acidos grasos poliinsaturados.
US20220287345A1 (en) 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
FR2215212B1 (ja) * 1973-01-18 1976-03-05 Seperic Ch
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
GB2118437B (en) * 1982-03-01 1984-12-12 Efamol Ltd Composition for treating alcoholism
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
DE3229956A1 (de) * 1982-08-12 1984-02-16 Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf Arzneimittel mit cytostatischer wirkung
DE3514328C1 (de) * 1985-04-19 1986-09-11 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg Verwendung von L-Ornithin bei der selektiven Hemmung von cytotoxischen T-Lymphozyten-Effektorzellen
ATE88631T1 (de) * 1986-09-17 1993-05-15 Clintec Nutrition Co Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DE3878812T2 (de) * 1987-02-20 1993-07-22 Shriners Hospitals For Cripple Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung

Also Published As

Publication number Publication date
FR2628324B1 (fr) 1994-05-27
SE8900828L (sv) 1989-09-10
GB2216418B (en) 1991-12-11
SE8900828D0 (sv) 1989-03-09
LU87471A1 (fr) 1990-10-02
IT8919704A0 (it) 1989-03-09
GB8905385D0 (en) 1989-04-19
GB2216418A (en) 1989-10-11
BE1002890A3 (fr) 1991-07-16
HUT60432A (en) 1992-09-28
FI94591C (fi) 1995-10-10
FI94591B (fi) 1995-06-30
IT1229562B (it) 1991-09-04
JPH01316316A (ja) 1989-12-21
DE3907649A1 (de) 1989-09-28
HU209973B (en) 1995-01-30
KR890014103A (ko) 1989-10-21
FI891145A (fi) 1989-09-10
FI891145A0 (fi) 1989-03-09
NL8900574A (nl) 1989-10-02
FR2628324A1 (fr) 1989-09-15
CH678918A5 (ja) 1991-11-29
DE3907649C2 (de) 1996-07-11

Similar Documents

Publication Publication Date Title
CA1334576C (en) Antiviral pharmaceutical compositions and process for preparing same
KR890009967A (ko) 아데노신 유도체
CA1339147C (en) Salt-type compounds, pharmaceutical compositions containing them and process for preparing same
IL82459A (en) Stabilized pharmaceutical preparations containing polyunsaturated fatty acids and stimulating the synthesis of prostaglandins and hydroxy- and fatty acids in B systems
JP4976307B2 (ja) 新規な抗ウイルス性および免疫刺激性の医薬組成物
US5869714A (en) Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
DE3684514D1 (de) Verwendung von penicillamin zur behandlung von immunmangelkrankheiten.
SE8406555D0 (sv) A process for obtaining ready-for-fertilization sexual products from sexually mature fish
AU566974B2 (en) Pharmaceutical preparations containing a phospholipidan an oxicam derivative
Chen et al. Some immunological effects of penicillamine.
EP0301474A3 (en) New cysteine derivatives having expectorant activity
US4845130A (en) Antihyperlipidemic amines
DE3627759A1 (de) Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine
AU611304B2 (en) Method of modifying the lipid structure of cell membranes
MX174421B (es) Procedimiento para la preparacion de 4-arilcarbonil-1-[(4-morfolinil)-alquilo-inferior]-1h-indoles y producto obtenido
GB2316406A (en) Free radical scavenger molecules

Legal Events

Date Code Title Description
MKLA Lapsed